CD6 and myeloid sarcoma: In a large genetic study of CD6, ALCAM and neuroinflammation, a polymorphism of ALCAM (rs579565G>A) and two SNPs of CD6 (rs17824933C>G and rs12360861G>A) were found to be strongly associated with risk, development and progression of MS.